课题基金 / 基金详情

Hypoxia-activated pro-drugs: A novel approach for breast cancer treatment

Hypoxia-activated pro-drugs: A novel approach for breast cancer treatment
缺氧激活的前药：乳腺癌治疗的新方法
批准号：
206200
负责人：
Saggar Jasdeep K
金额：
$7.65万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-10-01 至 2012-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=206200&lang=en
关键词：
Breast Cancer Chemotherapy Drug Resistance Hypoxia Pro-Drugs Repopulation Solid Tumors Treatment

项目摘要

项目成果

Saggar Jasdeep K的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is a major cause of death and disability in women. Chemotherapy is commonly used for treatment of breast cancer that has spread and is also given before or after breast surgery to prevent recurrence of cancer. Chemotherapy drugs target and
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the potential of chemotherapy and bradykinin inhibitors combination therapy to increase drug distribution in solid tumors
  • 批准号：
    297040
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.44万
  • 财政年份：
    2013
  • 负责人：
    Saggar Jasdeep K
  • 依托单位：
    Universidade de Sao Paulo (Brazil)
海外基金